Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
J Infect Dis. 2023 Sep 15;228(6):783-791. doi: 10.1093/infdis/jiad142.
Up to 26% of urogenital Chlamydia trachomatis infections spontaneously resolve between detection and treatment. Mechanisms governing natural resolution are unknown. We examined whether bacterial vaginosis (BV) was associated with greater chlamydia persistence versus spontaneous clearance in a large, longitudinal study.
Between 1999 and 2003, the Longitudinal Study of Vaginal Flora followed reproductive-age women quarterly for 1 year. Baseline chlamydia screening and treatment were initiated after ligase chain reaction testing became available midstudy, and unscreened endocervical samples were tested after study completion. Chlamydia clearance and persistence were defined between consecutive visits without chlamydia-active antibiotics (n = 320 persistence/n = 310 clearance). Associations between Nugent score (0-3, no BV; 4-10, intermediate/BV), Amsel-BV, and chlamydia persistence versus clearance were modeled with alternating and conditional logistic regression.
Of chlamydia cases, 48% spontaneously cleared by the next visit (310/630). Nugent-intermediate/BV was associated with higher odds of chlamydia persistence (adjusted odds ratio [aOR] = 1.89; 95% confidence interval [CI], 1.30-2.74), and the findings were similar for Amsel-BV (aOR 1.39; 95% CI, .99-1.96). The association between Nugent-intermediate/BV and chlamydia persistence was stronger in a within-participant analysis of 67 participants with both clearance/persistence intervals (aOR = 4.77; 95% CI, 1.39-16.35). BV symptoms did not affect any results.
BV is associated with greater chlamydia persistence. Optimizing the vaginal microbiome may promote chlamydia clearance.
在检测到和治疗之间,多达 26%的泌尿生殖道沙眼衣原体感染会自发痊愈。控制自然痊愈的机制尚不清楚。我们在一项大型纵向研究中检查了细菌性阴道病(BV)是否与衣原体持续存在而不是自发清除有关。
1999 年至 2003 年,阴道菌群纵向研究每季度对育龄妇女进行一次随访,为期 1 年。在研究进行到一半时,可利用连接酶链反应检测后,开始进行衣原体筛查和治疗,在研究完成后,检测未经筛查的宫颈内样本。在没有使用治疗衣原体的活性抗生素的连续就诊之间(n = 320 例持续感染/n = 310 例清除)定义了衣原体清除和持续感染。使用交替和条件逻辑回归模型,研究了 Nugent 评分(0-3,无 BV;4-10,中间/BV)、Amsel-BV 与衣原体持续感染和清除之间的关系。
在衣原体病例中,48%(310/630)在下一次就诊时自发清除。Nugent 中间/BV 与衣原体持续感染的可能性更高相关(调整后的优势比 [aOR] = 1.89;95%置信区间 [CI],1.30-2.74),Amsel-BV 的结果也相似(aOR 1.39;95% CI,0.99-1.96)。在 67 名同时具有清除/持续感染间隔的参与者的参与者内分析中,Nugent 中间/BV 与衣原体持续感染之间的关联更强(aOR = 4.77;95% CI,1.39-16.35)。BV 症状没有影响任何结果。
BV 与衣原体持续存在有关。优化阴道微生物群可能会促进衣原体清除。